Celyad Oncology
Biotechnology / Therapeutics / Pharma
Information
" Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. The Company is developing a pipeline of allogeneic (off-the-shelf) and autologous (personalized) CAR T cell therapy candidates for the treatment of both hematological malignancies and solid tumors. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium and New York, NY. The Company has received funding from the Walloon Region (Belgium) to support the advancement of its CAR T cell therapy programs."
🚀 Do you want to explore opportunities at Celyad Oncology? Please visit https://celyad.com/contact-us/careers/
Sponsor Type
Exhibitor